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Background: Nuclear factor-kappaB (NF-κB) is an inducible transcription factor that plays a key role in inflammation
and immune responses, as well as in the regulation of cell proliferation and survival. Previous studies by our group
and others have demonstrated that porcine reproductive and respiratory syndrome virus (PRRSV) infection could
activate NF-κB in MARC-145 cells and alveolar macrophages. The nucleocapsid (N) protein was identified as an
NF-κB activator among the structural proteins encoded by PRRSV; however, it remains unclear whether the
nonstructural proteins (Nsps) contribute to NF-κB activation. In this study, we identified which Nsps can activate
NF-κB and investigated the potential mechanism(s) by which they act.
Results: By screening the individual Nsps of PRRSV strain WUH3, Nsp2 exhibited great potential to activate NF-κB in
MARC-145 and HeLa cells. Overexpression of Nsp2 induced IκBα degradation and nuclear translocation of NF-κB.
Furthermore, Nsp2 also induced NF-κB-dependent inflammatory factors, including interleukin (IL)-6, IL-8, COX-2, and
RANTES. Compared with the Nsp2 of the classical PRRSV strain, the Nsp2 of highly pathogenic PRRSV (HP-PRRSV)
strains that possess a 30 amino acid (aa) deletion in Nsp2 displayed greater NF-κB activation. However, the 30-aa
deletion was demonstrated to not be associated with NF-κB activation. Further functional domain analyses revealed
that the hypervariable region (HV) of Nsp2 was essential for NF-κB activation.
Conclusions: Taken together, these data indicate that PRRSV Nsp2 is a multifunctional protein participating in the
modulation of host inflammatory response, which suggests an important role of Nsp2 in pathogenesis and disease
outcomes.
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Porcine reproductive and respiratory syndrome (PRRS) is
characterized by severe reproductive failure in sows, and
respiratory distress in piglets and growing pigs, and con-
tinues to be the most economically significant disease in
the swine industry [1,2]. The causative agent, PRRS virus
(PRRSV), is an enveloped, single-stranded positive sense
RNA virus containing a genome of approximately 15 kb
[3]. The 5’ two-thirds of the viral genome is occupied by
overlapping open reading frames 1a (ORF1a) and 1b,
which encode nonstructural polyproteins (Nsp), pp1a
and pp1ab, respectively [4,5]. These polyproteins are* Correspondence: vet@mail.hzau.edu.cn
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reproduction in any medium, provided the orproteolytically processed into 14 nonstructural proteins
(Nsp1α, Nsp1β, and Nsp2 to 12) [6-8]. In 2006, an atypical
PRRS outbreak in China was caused by an emerging
highly-pathogenic PRRSV (HP-PRRSV) strain with a dis-
continuous deletion of 30-amino acid in the Nsp2 coding
region in comparison with classical PRRSV strains [9,10].
Since then, the HP-PRRSV strain, which caused a more
severe pneumonia and higher mortality than the classical
PRRSV, has become the dominant strain found in China
[11,12]. The immense genetic variability in the coding
region of Nsp2 suggests that Nsp2 may play a limited role
in viral replication but likely to play a very important part
in modulating virus pathogenesis and the inflammation
response in pigs during infection [13-16].
NF-κB is a family of inducible transcription factors
involving pathogen- or cytokine-induced immune andd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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survival [17-20]. The members of the NF-κB family in
mammalian cells include p50/p105 (NFκB1), p65 (RelA),
p52/p100 (NFκB2), c-Rel, and RelB. All of these proteins
share a conserved 300-amino acid region known as the Rel
homology domain that is responsible for DNA binding,
dimerization, and nuclear translocation of NF-κB. In most
cells, Rel family members form hetero- and homodimers
with distinct specificities in various combinations
[21,22]. Classical NF-κB exists as heterodimers consist-
ing of a 50-kDa subunit (p50) and a 65-kDa subunit (p65)
[23]. Under normal physiological conditions, NF-κB is
sequestered in the cytoplasm as inactive complexes by its
interaction with a member of the inhibitory kappa B (IκB)
family. When stimulated with a wide range of proinflam-
matory stimuli, the IκB proteins are phosphorylated by IκB
kinase (IKK) and degraded in proteasomes [24]. The sub-
unit of NF-κB p65 is then phosphorylated while exposing
its nuclear localization signal sequence (NLS), leading to
nuclear translocation and subsequent binding of NF-κB to
DNA regulatory elements of the target genes involved in
various biological functions [6,21-23,25].
Many viruses encode proteins that activate or modu-
late NF-κB signalling pathways for their own advantage
[26]. For example, UL37 tegument protein, encoded by
herpes simplex virus 1 (HSV-1) interacts with tumour
necrosis factor (TNF) receptor-associated factor 6
(TRAF6), resulting in the NF-κB activation [27]. Simi-
larly, NF-κB activation induced by Hepatitis C virus
(HCV) core protein and Epstein–Barr virus latent mem-
brane protein 1 (LMP1) is important for infected cell
survival and persistent viral infection [28,29]. Previous
studies of PRRSV have demonstrated that the nucleocap-
sid (N) protein was a NF-κB activator [30-32]; however,
it remains unclear whether the PRRSV Nsps contribute
to NF-κB activation. The current study demonstrated
that PRRSV Nsp2 alone could activate the NF-κB signal-
ling pathway and the potential molecular mechanism(s)
for NF-κB activation were also investigated.
Results and discussion
PRRSV Nsp2 activates NF-kB
To identify the specific PRRSV Nsp(s) involved in NF-κB
activation, all non-structural genes of PRRSV strain WUH3
[33] were screened for their capacities to activate NF-κB
using a luciferase reporter assay. As shown in Figure 1A,
overexpression of Nsp2 in HeLa cells potently induced
NF-κB activation, while this activation was not observed in
cells overexpressing other viral nonstructural proteins. To
further confirm the effect of Nsp2 on NF-κB, HeLa cells
were transfected with increasing amounts of Nsp2 expres-
sion plasmid and NF-κB luciferase activity was monitored
at 36 h post-transfection. As shown in Figure 1B, a dose-
dependent increase in luciferase reporter activity wasobserved. These data clearly indicated that Nsp2 was
responsible for the induction of NF-κB activation among
PRRSV nonstructural proteins. Similar results were
obtained using MARC-145 cells overexpressing Nsp2 (data
not shown).
Nsp2 induced degradation of IκBα and nuclear
translocation of NF-κB
Activation of NF-κB is usually characterized by degrad-
ation of IκBα after phosphorylation by IKK in response to
many extracellular stimuli, which is followed by the phos-
phorylation of NF-κB subunit p65 (RelA) and nuclear
translocation of NF-κB [19,22]. To investigate the potential
mechanism(s) of NF-κB activation by Nsp2, we first exam-
ined the IκBα expression level in the cytoplasmic extracts
using a western blot assay. As shown in Figure 2A, the
IκBα protein degraded in a dose-dependent manner in
Nsp2-transfected cells. To further characterize the mech-
anism, the phosphorylation and the nuclear translocation
of the p65 subunit, as well as the total p65 in Nsp2 expres-
sion cells were determined. As shown in Figure 2A, the
amount of phosphorylated p65 and nuclear p65 protein
increased in a dose-dependent manner, while the amount
of total p65 was unaltered. To further validate NF-κB
nuclear translocation after Nsp2 overexpression, HeLa
cells co-transfected with enhanced green fluorescent pro-
tein (EGFP)-p65 and red fluorescent protein (RFP)-Nsp2
fusion expression constructs were used to monitor the
translocation of p65 by confocal fluorescence microscopy.
As shown in Figure 2B, the p65 protein accumulated in
the nucleus when co-expressed with Nsp2, while it was
retained in the cytoplasm when co-expressed with the
empty vector or expressed alone.
Overall, these results clearly demonstrated that Nsp2
induced NF-κB activation characterized by IκBα degrad-
ation and p65 nuclear translocation, which is consistent
with a recent publication showing that PRRSV infection
modulates NF-κB activation through IκBα degradation
in vitro [31]. The observation that Nsp2 induced IκBα deg-
radation raised the possibility that Nsp2 may have affected
upstream processing for IκB phosphorylation from which
the dissociation of the NF-κB-IκB complex and subsequent
p65 nuclear translocation was dependent.
PRRSV Nsp2 significantly enhanced NF-κB-regulated gene
expression
NF-κB is a critical transcription factor regulating the tran-
scription and expression of many pro-inflammatory mole-
cules, including certain adhesion molecules (ICAM-1),
critical enzymes (for example, COX-2), most cytokines (for
example, IL-1β, IL-6, and TNF-α), and chemokines (for
example, IL-8 and RANTES) [19,34]. Previous studies have
shown that PRRSV infection can induce several cytokines,
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Figure 1 PRRSV Nsp2 activates NF-κB. (A) HeLa cells were co-transfected with the NF-κB-Luc reporter plasmid (0.2 μg), pRL-TK plasmid (0.05 μg),
along with 0.6 μg of the indicated expression plasmid encoding PRRSV nonstructural protein. Selected cells were stimulated by 20 ng/ml TNF-α at
30 h post-transfection, and whole-cell extracts were prepared for the dual-luciferase activity at 6 h after this treatment. **P< 0.01 as compared with
vector control. (B) An increasing quantities of indicated Nsp2 expression plasmid (0, 0.1, 0.2, 0.4, 0.8 μg) was co-transfected with pNF-κB-Luc and
pRL-TK into HeLa cells. Cells were harvested at 36 h after transfection and analysed for luciferase activity. (a) P< 0.05 compared with the vector group,
(b) P< 0.05 compared with 0.1 μg Nsp2 protein transfection group, (c) P< 0.05 compared with 0.2 μg Nsp2 protein transfection group, (d) P< 0.05
compared with 0.4 μg Nsp2 protein transfection group. Values for the samples were normalized using Renilla luciferase values and expressed as
relative fold change in NF-κB-regulated gene expression compared with vector group, and each untreated empty vector control value was set as a
basis level of 1. Data represent means of three replicates and results are representative of at least three independent experiments.
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response [34,35]. To further investigate the possible bio-
logical impact of Nsp2 on pro-inflammatory molecules, a
promoter luciferase reporter assay was used to determine
if Nsp2 enhanced NF-κB-regulated target gene expression,
including IL-6, IL-8, COX-2, and RANTES. As shown in
Figure 3A, overexpression of Nsp2 enhanced the promoter
activities of IL-6, IL-8, COX-2, and RANTES to varying
degrees. To further confirm these results, the mRNA
expression of these cytokines was detected by real-time
reverse transcription-polymerase chain reaction (RT-PCR).
As shown in Figure 3B, gene expression data were consist-
ent with the promoter-driven luciferase reporter assay.
Interestingly, as a result of treatment with the NF-κB
inhibitor, BAY-117082, Nsp2 exhibited reduced ability to
upregulate IL-6, IL-8, COX-2, and RANTES expression ina dose-dependent manner (data not shown). These obser-
vations suggest that Nsp2 stimulated cytokine expression
via the NF-κB signalling pathway.The 30-amino acid deletion in the Nsp2 of HP-PRRSV has
no effect on NF-κB activation
Compared with the classical PRRSV strains, animals
infected with HP-PRRSV typically show a more severe
pneumonia. It is well known that NF-κB is an important
transcription factor for mediating virus-induced inflam-
matory responses, such as severe lung inflammation and
diseases [19,36]. Thus, we assessed the ability of Nsp2
from different PRRSV strains to activate NF-κB using a
luciferase reporter assay. As shown in Figure 4A, Nsp2
of HP-PRRSV strains (WUH3 and 07HBEZ) could
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Figure 2 Degradation of IκBα and nuclear translocation of p65 are induced by PRRSV Nsp2. (A) HeLa cells were transfected with the
indicated amount (0, 1, 2, 4 μg) of Nsp2 expression plasmid. Cytoplasmic and nuclear extracts were prepared at 48 h post-transfection and
subjected to western blot analysis with antibodies specific for endogenous IκBα, p65 or p-p65. Mouse anti-HA was used to confirm the expression
of HA-conjugated Nsp2 protein. Anti-β-actin was included as a control for sample loading. Western blot analyses were repeated in two
independent experiments with similar results and a representative blot was shown. (B) HeLa cells were co-transfected with RFP-tagged Nsp2
expression plasmid (pDsRed-Nsp2) and the EGFP-tagged p65 expression plasmid (pEGFP-p65). Cells co-transfected with pDsRed-C1 and
EGFP-tagged p65 served as a negative control. Cells were fixed and permeabilized at 36 h post-transfection. Cellular nuclei were counterstained
with 1 μg/mL of DAPI (4',6-diamidino-2-phenylindole, dihydrochloride). Nuclear translocation of NF-κB was observed under an LSM-510 Meta
confocal fluorescence microscope. Scale bar represents 5 μm.
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the classical PRRSV strain CH-1a (P< 0.01).
Amino acid sequence alignment revealed that the Nsp2
of WUH3 and 07HBEZ possessed the same 30 amino acid
discontinuous deletion [37]. Thus, we investigated whether
these deletions have any effect on NF-κB activation. To
test this hypothesis, we constructed several insertion
mutants in Nsp2 expression plasmids based on the Nsp2
of PRRSV strain WUH3, which were denoted as Nsp2(+1),
Nsp2(+29), and Nsp2(+1/+29). These mutants were then
analysed for their capacities of stimulating NF-κB in HeLa
cells. These assays showed that NF-κB activation by these
Nsp2 insertion mutants was equivalent to that of the wild-
type Nsp2 (Figure 4B) (P> 0.05). Additionally, insertionswithin this region did not result in the loss of the ability to
activate NF-κB, suggesting that the 30 amino acids discon-
tinuous deletion in the Nsp2 coding region is not related
to NF-κB activation.
Taken together, the variable effect on Nsp2-induced
NF-κB activation might be a factor contributing to the
different levels of viral pathogenesis between different
PRRSV strains. However, the underlying mechanism may
be due to the different capacities of replication or the
alternative strategies in NF-κB activation by different
PRRSV strains. Using a series of chimeric viruses where
the deletion region was substituted with corresponding
regions of low virulence strains, Zhou et al. elucidated
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Figure 3 PRRSV Nsp2 significantly enhances NF-κB-regulated gene expression. (A) The wild-type Nsp2 (0.6 μg) and the empty vector were
transfected into HeLa cells along with various reporter plasmids (0.2 μg) and pRL-TK (0.05 μg), respectively. Luciferase reporter assays were
performed at 36 h post-transfection. The results are expressed as fold induction of IL-6, IL-8, COX-2, and RANTES promoter luciferase activity
relative to the basal level. (B) HeLa cells were transfected with 1 μg of plasmid encoding Nsp2, or empty vector. After 36 h incubation, total RNA
was extracted and the expression of IL-6, IL-8, COX-2, RANTES, and GAPDH genes were evaluated by real-time RT-PCR. Results are expressed as
increasing mRNA levels relative to those in cells transfected with the empty vector and were normalized by using GAPDH housekeeping gene
expression. All data represent the means and standard deviation of three independent experiments. **P< 0.01 as compared with vector control.
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http://www.virologyj.com/content/9/1/83of virulence of HP-PRRSV. These findings are consistent
with those in the current study that found there was no
direct association between NF-κB activation and the 30-aa
deletion in Nsp2. In addition, our investigation showed
that Nsp2 specifically localized to the mitochondria (data
not shown). Previous studies have demonstrated that the
mitochondria played an important role in the activation of
NF-κB and interferon regulatory factor (IRF)3 mediated by
mitochondrial antiviral signalling (MAVS) in response to
viral infection [38]. Whether the localization of Nsp2 in
the mitochondria is essential for its capacity for NF-κB
activation requires further investigation.
Functional domain of Nsp2 for NF-κB activation
Since the 30-aa deletion in Nsp2 is not associated with its
ability to activate NF-κB, we attempted to further map the
domain responsible for in NF-κB activation. To this end, six
truncated mutants of Nsp2 were constructed (Figure 5A)
and a NF-κB reporter assay was performed to determinethe functional region responsible for NF-κB activation. As
shown in Figure 5B, several mutants, including the HV
(hypervariable region), ΔPL2 (the putative enzyme domain
truncated mutant), ΔTM (the transmembrane region trun-
cated mutant), which all contain the HV domain, showed a
significant increase in NF-κB luciferase activity. However,
luciferase activity was significantly reduced in other
mutants that did not contain these regions compared with
wild-type Nsp2 (P< 0.01). This suggested that the func-
tional domain responsible for NF-κB activation might be
located in the middle HV of Nsp2.
Previous studies performed by Sun and co-workers
[39] showed that the PRRSV Nsp2 OTU domain inhib-
ited NF-κB activation by interfering with the polyubiqui-
tination process of IκBα. These findings are consistent
with our result that show the PL2 domain of PRRSV
Nsp2 failed to activate NF-κB when expressed independ-
ently; however, the HV region of Nsp2 could activate









































































Figure 4 Amino acid deletion was not necessary for Nsp2 induced activation of NF-κB. (A) HeLa cells were co-transfected with the NF-κB-
Luc reporter plasmid (0.2 μg), 0.05 μg of pRL-TK, and the designated Nsp2 expression plasmids (0.6 μg). An empty vector was used as a control.
Cell extracts were collected at 36 h post-transfection and analysed for luciferase expression. (a) P< 0.05 compared with the vector group, (b)
P< 0.05 compared with Nsp2 (CH-1a) protein transfection group. (B) Distinct insertion mutants or wild-type Nsp2 were transfected into HeLa cells
together with NF-κB-Luc (0.2 μg) and pRL-TK (0.05 μg). Cell lysates were prepared at 36 h post-transfection and subjected to a dual-luciferase
assay. There was no significant statistical difference between the wild-type Nsp2 and its mutants to activate NF-κB (P> 0.05).
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ase subunit with different domains involved in different
functions in viral replication and pathogenesis. In
addition, the activation of NF-κB has been previously
described in PRRSV-infected MARC-145 cells and alveo-
lar macrophages [31,32]. However, recent studies have
reported that several PRRSV Nsps, including Nsp1α,
Nsp1β, Nsp11, could function as negative regulators of
NF-κB to escape the host innate immune response
[14,40]. Furthermore, studies from our laboratory
showed that the N protein of PRRSV could induce NF-
κB activation [41]. Taken together, these studies suggest
that PRRSV might have developed sophisticated strat-
egies for either activation or inhibition of NF-κB pathway
to survive in host cells. Further investigation is requiredto evaluate the exact mechanisms involved in PRRSV-
induced modulation of the NF-κB pathway.
Conclusions
In summary, our data clearly demonstrated that the
PRRSV Nsp2 alone, in the absence of other PRRSV pro-
teins, could significantly activate the NF-κB pathway.
Overexpression of PRRSV Nsp2 induced the NF-κB-
dependent pro-inflammatory molecules, IL-6, IL-8, COX-
2, and RANTES. The 30-aa deletion in the Nsp2 of HP-
PPRSV was not associated with NF-κB activation; however,
the hypervariable region of Nsp2 was essential for NF-κB
activation. This study not only helps clarify the molecular
mechanisms of NF-κB activation during PRRSV infection
but also helps explain the ability of PRRSV Nsp2 to
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Figure 5 Characterization of the Nsp2 domains responsible for inducing NF-κB activation. (A) Schematic representation of various
truncated mutants of PRRSV Nsp2 used in this study. PL2, the putative enzyme domain; HV, the hypervariable region; TM, the transmembrane
region. (B) HeLa cells were co-transfected with the 0.2 μg of pNF-κB-Luc, 0.05 μg of pRL-TK, and the distinct truncations of Nsp2 expression
plasmids (0.6 μg). An empty vector was used as a control. At 30 h after transfection, one group of cells with empty vector transfected was
stimulated with 20 ng/mL of TNF-α. Cell extracts were collected at 36 h after the initial transfection and analysed for luciferase expression. **
P< 0.01 as compared with vector control.
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κB pathway. Understanding the relationships between
PRRSV Nsp2 and the host inflammatory responses should
help develop more effective strategies for the control of
PRRS.Materials and methods
Cells, viruses, and antibodies
HeLa and MARC-145 cells were cultured and maintained
in Dulbecco’s modified Eagle medium (DMEM) supple-
mented with 10% heat-inactivated fetal bovine serum
(FBS), 100 U/mL penicillin, 10 μg/mL streptomycin sulfate
and then incubated at 37°C in a humidified 5% CO2 incu-
bator. HP-PRRSV strain WUH3 (GenBank Accession No.:
HM853673.2), a virulent strain, was isolated from the
brain of a pig with the “high fever” syndrome in China at
the end of 2006 and identified as a highly pathogenic
North American type PRRSV [33]. PRRSV strain CH-1a
(GenBank Accession No.: AY032626), the first field isolate
in China, was kindly provided by Dr. Guangzhi Tong
(Shanghai Veterinary Research Institute, Shanghai,
China) [42]. Monoclonal antibody (mAb) anti-HA was
purchased from Sigma (St. Louis, MO). Polyclonal anti-
bodies (pAb), anti-β-actin, p65, p-p65, IκBα, were pur-
chased from Santa Cruz (Santa Cruz, CA). Horseradishperoxidase-conjugated anti-mouse or anti-rabbit IgG
antibodies were purchased from Beyotime Institute of
Biotechnology (Jiangsu, China).Plasmids
Plasmids were constructed by standard methods. Expres-
sion plasmids of PRRSV nonstructural proteins used in this
report were constructed by RT-PCR amplification from the
genomic RNA of PRRSV strain WUH3. Mutagenesis of 1
or/and 29 amino acids in Nsp2 was performed using the
Overlap Extension Polymerase Chain Reaction. Six trun-
cated mutants of Nsp2 were generated by PCR from
WUH3 cDNA. All PCR amplification reactions were per-
formed by PrimerSTAR™ HS DNA Polymerase system
(TaKaRa Biotechnology, Dalian, China). The details of the
specific primers used in PCR steps are available on request.
Gene fragments were cloned into the pCAGGS-HA
vector in-frame that was constructed using the pCAGGS
vector (Stratagene, Santa Clara, CA) to generate a series
of PRRSV nonstructural protein constructs and Nsp2
mutants for expression in mammalian cells. All con-
structs were confirmed by sequencing and the expres-
sions of the interested protein were verified by western
blot analysis using anti-HA antibody (data not shown).
The expression plasmid of Nsp2 of PRRSV 07HBEZ
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HM595639) was kindly provided by Dr H. X. Li [43].
Full-length Nsp2 of CH-1a strain was amplified from the
cDNA of CH-1a. The luciferase reporter plasmid pNF-
κB-Luc contains four repeats of κB binding motifs fol-
lowed by the luciferase reporter gene (Luc) and the
internal control plasmid pRL-TK were purchased from
Stratagene. Other reporter plasmids, such as IL-6-Luc,
IL-8-Luc, RANTES-Luc, and COX-2-Luc, were con-
structed as previously described [34,44]. The p65 gene
was derived from human RelA cDNA and cloned into
the pEGFP-C1 vector. The DNA fragment containing
the entire open reading frame (ORF) of Nsp2 was
excised from pCAGGS-HA-Nsp2 and inserted into the
pDsRed-C1 (Clontech, Mountain View, CA), resulting in
the expression construct pDsRed-Nsp2.
Transfection and luciferase reporter assay
Transient transfection was performed using Lipofectamine
2000 (Invitrogen). HeLa or MARC-145 cells were seeded
on 24-well plates (Nunc, Roskilde, Denmark) at a density
of 2–4 × 105 cells/well and cultured until the cells reached
approximately 70–80% confluence, and were then trans-
fected with the indicated plasmids. For each transfection,
0.2 μg of the reporter plasmid (NF-κB, IL-6, IL-8, COX-2,
RANTES-Luc) along with 0.05 μg of pRL-TK for
normalization and 0.6 μg of various expression plasmids
or empty control plasmid (pCAGGS-HA) were used. In
addition to serving as a negative control, the empty vector
was also used to adjust the total amount of transfected
DNA to 1.05 μg in dose-dependent experiments. Cells
treated with 20 ng/mL of TNF-α (Sigma) for 6 h prior to
harvest were used as a positive control. Cell extracts were
collected at the indicated time points. Firefly and Renilla
luciferase activities were measured using the Dual-lucifer-
ase reporter assay system (Promega, Madison, WI) in a
MicroBeta TriLux liquid scintillation and a luminometer
(Turner BioSystems, Sunnyvale, CA), according to the











R: CTTCGACGCCTGCTTCACCellular extracts and western blot assay
Cytoplasmic and nuclear protein extracts from HeLa cells
after transfection with Nsp2-expression plasmid were pre-
pared with the Cytoplasmic Extraction Reagent (100 mM
HEPES [pH 8.0], 1% NP40, 15 mM MgCl2, 100 mM KCl,
5 mM DTT, 2 mM Sucrose, 1% Cocktail) and Nuclear Ex-
traction Reagent (200 mM HEPES [pH 7.9], 15 mMMgCl2,
4.2 mM NaCl, 5 mM DTT, 5 mM EDTA, 1% Cocktail), re-
spectively. Protein concentration was determined by Micro
BCA Protein Assay (Thermo, Rockford, IL) with bovine
serum albumin as a standard following the manufacturer’s
protocols. The extracts were boiled in sodium dodecyl
sulphate (SDS) protein sample buffer (2% SDS, 60 mMTris–HCl [pH 6.8], 10% glycerol, 0.001% bromophenol
blue, and 0.33% β-mercaptoethanol), then resolved by 10%
acrylamide sodium dodecyl sulphate polyacrylamide gel
electrophoresis (SDS-PAGE). The separated proteins were
electroblotted onto a PVDF membrane (Millipore, Billerica,
MA). Membranes were blocked with 5% (w/v) dried skim
milk in tris-buffered saline containing Tween 20 (TBST).
Western blotting was performed using a standard techni-
ques, using anti-HA monoclonal antibody, anti-p65, p-p65,
IκBα and β-actin polyclonal antibodies at a dilution of
1:1,000. Secondary antibodies, horseradish peroxidase-
conjugated anti-mouse and anti-rabbit IgG antibody,
were used at a dilution of 1:2,500, and protein bands were
visualized using SuperSignal West Pio Luminol kit (Pierce).
Confocal fluorescence microscopy
HeLa cells were seeded on microscope coverslips placed
in 24-well plates at a concentration of 2 × 105 cells/well
until the cells reached approximately 70–80% conflu-
ence. The pEGFP-p65 was co-transfected with pDsRed1-
Nsp2, as well as the empty vector pDsRed-C1. At 36 h
post-transfection, cells were fixed with 4% paraformalde-
hyde for 10 min followed by permeabilization with 0.1%
Triton X-100 for 10 min at room temperature (RT).
After three washes with PBS, cells were incubated with
DAPI for 5 min at room temperature. After washing with
PBS, fluorescent images were performed using confocal
laser scanning microscope (LSM 510 Meta; Carl Zeiss
MicroImaging, Göttingen, Germany).
RNA exaction and quantitative real-time RT-PCR
To determine the effect of Nsp2 on IL-6, IL-8, COX-2
and RANTES, HeLa cells grown in 24-well plates were
transfected with 1 μg of plasmid encoding Nsp2. The
empty vector served as a negative control. Total RNA
were extracted from the transfected cells 36 h post-
transfection using TRIzol reagent (Invitrogen). Real-
time RT-PCR was performed using SYBR Green Real
Fang et al. Virology Journal 2012, 9:83 Page 9 of 10
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with primer pairs described in Table 1 in the LightCycler
480 (Roche Molecular Biochemicals). Individual transcripts
in each sample were ass ayed three times and normalized
with human glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) mRNA level as an endogenous control. Primers
were designed using the Primer Express software (version
3.0; Applied Biosystems, Carlsbad, CA).
Statistical analysis
All experiments were performed at least three times with
reproducible results. Data were presented as means ±
standard deviations (SD). The Student’s t-test was used to
determine statistical significance. P-values less than 0.05
were considered statistically significant, and P-values less
than 0.01 were considered highly significant.
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